Want to see ICU full AI Analyst Report?
Total Valuation
SeaStar Medical Holding has a market cap or net worth of $14.01M. The enterprise value is $8.16.
Market Cap$14.01M
Enterprise Value$8.16
Share Statistics
SeaStar Medical Holding has 4,406,841 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,406,841
Owned by Insiders3.44%
Owned by Institutions<0.01%
Financial Efficiency
SeaStar Medical Holding’s return on equity (ROE) is -1.17 and return on invested capital (ROIC) is -111.28%.
Return on Equity (ROE)-1.17
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-111.28%
Return on Capital Employed (ROCE)-1.17
Revenue Per Employee72.59K
Profits Per Employee-714.71K
Employee Count17
Asset Turnover0.09
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of SeaStar Medical Holding is ―. SeaStar Medical Holding’s PEG ratio is 0.00449.
PE Ratio―
PS Ratio40.32
PB Ratio4.78
Price to Fair Value4.78
Price to FCF-3.66
Price to Operating Cash Flow-0.97
PEG Ratio0.00449
Income Statement
In the last 12 months, SeaStar Medical Holding had revenue of 1.23M and earned -12.15M in profits. Earnings per share was -5.86.
Revenue1.23M
Gross Profit1.18M
Operating Income-12.18M
Pretax Income-12.15M
Net Income-12.15M
EBITDA-12.16M
Earnings Per Share (EPS)-5.86
Cash Flow
In the last 12 months, operating cash flow was -13.69M and capital expenditures 0.00, giving a free cash flow of -13.69M billion.
Operating Cash Flow-13.69M
Free Cash Flow-13.69M
Free Cash Flow per Share-3.11
Dividends & Yields
SeaStar Medical Holding pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.65
52-Week Price Change-60.82%
50-Day Moving Average3.62
200-Day Moving Average3.39
Relative Strength Index (RSI)42.77
Average Volume (3m)3.06M
Important Dates
SeaStar Medical Holding upcoming earnings date is Nov 18, 2026, After Close (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
SeaStar Medical Holding as a current ratio of 3.63, with Debt / Equity ratio of 0.00%
Current Ratio3.63
Quick Ratio3.61
Debt to Market Cap0.01
Net Debt to EBITDA0.94
Interest Coverage Ratio-37.01
Taxes
In the past 12 months, SeaStar Medical Holding has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
SeaStar Medical Holding EV to EBITDA ratio is -3.15, with an EV/FCF ratio of -2.82.
EV to Sales31.04
EV to EBITDA-3.15
EV to Free Cash Flow-2.82
EV to Operating Cash Flow-2.82
Balance Sheet
SeaStar Medical Holding has $6.96M in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.96M billion.
Cash & Marketable Securities$6.96M
Total Debt$0.00
Net Cash$6.96M
Net Cash Per Share$1.58
Tangible Book Value Per Share$0.50
Margins
Gross margin is 92.64%, with operating margin of -986.63%, and net profit margin of -984.60%.
Gross Margin92.64%
Operating Margin-986.63%
Pretax Margin-984.36%
Net Profit Margin-984.60%
EBITDA Margin-985.17%
EBIT Margin-986.63%
Analyst Forecast
The average price target for SeaStar Medical Holding is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast123.63%
EPS Growth Forecast83.96%